Status:
COMPLETED
Impact of Increased Protein Density Diet to Muscle Mass and Strength Among Mid-aged and Older Adults
Lead Sponsor:
National Yang Ming Chiao Tung University
Collaborating Sponsors:
Laurel Corporation, Taiwan
Conditions:
Muscle Loss
Muscle Weakness
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
The subjects of this intervention program are mainly based on community-dwelling mid-aged and older adults. The investigator's program will provide meals containing different proportionated protein.As...
Detailed Description
With aging, functions of every organs become to decline. Muscle mass, is one of the decline. According to previous research, adults would lose 40% among from aged 20 to 70. If muscle mass decline comb...
Eligibility Criteria
Inclusion
- People who aged 40-75 years
- Patients with following characteristics:
- feeling loss in activity
- detecting decline in self's walking speed.
- feeling tired of doing everything.
- having fell in last year.
- People can accept undergoing MRI
- People willing to follow the program and cooperate with us for following tracking.
- People who are neither vegan nor vegetarian
- People agree and be able to sign the informed consent.
Exclusion
- People cannot intake provided meals (e.g.: vegans or vegetarians) or any other who is allergic to our diets.
- People with any disease affecting their limbs, including:
- having fracture on limbs in the past 6 months
- having severe arthritis in the past 6 months
- any other whom PI recognized as weak control of their nervous system( e.g.: Parkinson's disease and stroke).
- People with intermittent limp caused by peripheral artery diseases
- People with weak control of mental disorder
- People with weak control of Cardiopulmonary disease
- People with weak control of Malignant tumor
- People with weak control of kidney diseases (eGFR \<60ml/min/1.73)
- People with Visual impairment and Hearing disorder which cannot help to complete the program.
- People who are unable to undertake MRI
- People who have underwent hormone treatment and planned to undergo hormone treatment during program session.
- Any other condition that PI recognized as not suitable
Key Trial Info
Start Date :
February 13 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03784456
Start Date
February 13 2019
End Date
December 31 2019
Last Update
February 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Yang Ming University
Taipei, Taiwan, 112